Last reviewed · How we verify

NCT06712992

Electromyographic Response to TsDcs in CNSLBP

Active, enrolled NA Last updated 12 March 2025
What this trial tests

NA trial testing Trans-spinal Direct Current Stimulation in Low Back Pain in 40 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
16 May 2024
Primary endpoint
1 April 2025
10 April 2025

Quick facts

Lead sponsorGerman International University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment40
Start date16 May 2024
Primary completion1 April 2025
Estimated completion10 April 2025
Sites2 locations across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

German International University

Who can join

Adults 18 to 60, any sex, with Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this randomized, double-blinded, sham-controlled study is to investigate the efficacy of trans-spinal direct current stimulation on pain level, quality of life, and electromyographic nociceptive flexion reflex in patients with non-specific chronic low back pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Other German International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06712992.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing